Pharmaceutical

Filter

Current filters:

None

Popular Filters

98 to 122 of 7172 results

New EU Internal Market and Industry Commissioner says parallel trade is lawful

New EU Internal Market and Industry Commissioner says parallel trade is lawful

10-12-2014

In September Enrico Gasbarra, a newly-elected Italian Member of the European Parliament (BEP) from the…

EuropeMarkets & MarketingPharmaceuticalPharmaceutical sciencesPolitics

Russian Ministry of Health reveals new classification of drugs for domestic market

Russian Ministry of Health reveals new classification of drugs for domestic market

10-12-2014

The Russian Ministry of Health has designed a new classification of drugs for the domestic pharmaceutical…

FinancialHealthcarePharmaceuticalPharmacologyRussia

Genesis One Nucleus 2014: personalized medicine and big data

Genesis One Nucleus 2014: personalized medicine and big data

10-12-2014

In the opening sessions at the Genesis One Nucleus 2014 conference in London yesterday, the main themes…

Evidence-based medicineHealth Medical PharmaInterviewsJohnson & JohnsonPharmaceuticalResearch

Takeda partners with Monash University on gastrointestinal research

Takeda partners with Monash University on gastrointestinal research

10-12-2014

Japan’s largest drugmaker Takeda has entered into a research partnership with the Monash Institute…

AustraliaGastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticals

Shire's guanfacine hydrochloride extended release reduces core ADHD symptoms in Phase III trial

Shire's guanfacine hydrochloride extended release reduces core ADHD symptoms in Phase III trial

10-12-2014

Ireland-headquartered drugmaker Shire has achieved positive results in a Phase III trial of guanfacine…

Guanfacine HydrochlorideIrelandNeurologicalPharmaceuticalResearchShire

Lundbeck and Otsuka present Phase III results of brexpiprazole in major depressive disorder

Lundbeck and Otsuka present Phase III results of brexpiprazole in major depressive disorder

10-12-2014

Japanese drug maker Otsuka and Danish CNS specialist Lundbeck have announced Phase III study results…

brexpiprazoleLundbeckNeurologicalOtsukaPharmaceuticalResearchUSA

Medical burden still heavy for Chinese

10-12-2014

Chinese medical reform fiscal measures have lined the pockets of hospitals and companies but not done…

ChinaFinancialHealthcarePharmaceutical

Medicines Australia welcomes new report on Australian pharma industry

Medicines Australia welcomes new report on Australian pharma industry

10-12-2014

A new report has found that the pharmaceutical and medical technology industries in Australia produce…

AustraliaFinancialMedicines AustraliaPharmaceuticalPharmaceuticals policy

FDA Focus: Life-threatening disease and the benefit-risk of treatment options

FDA Focus: Life-threatening disease and the benefit-risk of treatment options

10-12-2014

In the fifth of a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies…

ChemistryFDAPharmaceuticalRegulationUSA

ASH 2014: Gilead announces good response rates for Zydelig in non-Hodgkin lymphoma

ASH 2014: Gilead announces good response rates for Zydelig in non-Hodgkin lymphoma

09-12-2014

US biotech major Gilead Sciences has announced long-term follow-up results from the registration studies…

Gilead SciencesOncologyPharmaceuticalResearchUSAZydelig

Bayer collaborates with DNDi on novel, oral human river blindness treatment

09-12-2014

German pharma major Bayer and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement…

Astellas PharmaBayeremodepsidePharmaceuticalResearchTropical diseases

AstraZeneca’s Moventig gains EU approval for OIC

09-12-2014

The European Commission has granted marketing authorization for Anglo-Swedish pharma major AstraZeneca’s…

AstraZenecaEuropeGastro-intestinalsMoventigNektar TherapeuticsPharmaceuticalRegulation

India’s regulator approves Sun Pharma’s acquisition of Ranbaxy, but with conditions

India’s regulator approves Sun Pharma’s acquisition of Ranbaxy, but with conditions

09-12-2014

The Indian Competition Commission has granted domestic generics company Sun Pharmaceutical Industries…

IndiaMergers & AcquisitionsPharmaceuticalRanbaxySun Pharmaceutical

China’s new regulatory process could cause delays, RDPAC warns

China’s new regulatory process could cause delays, RDPAC warns

09-12-2014

Concerns have been raised in China that regulatory delays could defer the introduction of new drugs into…

BloombergChinaPharmaceuticalR&D-Based Pharmaceutical Association CommitteeRegulation

Europe’s research and generic/biosimilar industries join forces against counterfeiting

Europe’s research and generic/biosimilar industries join forces against counterfeiting

09-12-2014

Trade groups the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European…

ESMEuropeGenericsMarkets & MarketingPharmaceutical

"My staff are involved in setting the global healthcare agenda:" interview with Parexel's Thomas Senderovitz

08-12-2014

With so many balls to juggle in the development pathway of a new drug, pharma companies looking for support…

InterviewsParexelParexelPharmaceuticalResearchThomas Senderovitz

EFPIA responds to European Commission's patent settlement report with own transparency proposal

EFPIA responds to European Commission's patent settlement report with own transparency proposal

08-12-2014

The European Commission has published its fifth Monitoring Report of Patent Settlements in the pharma…

EuropeEuropean CommissionLegalPharmaceuticalRegulation

Roche's Gazyvaro and Bayer’s Adempas approved by Scottish Medicines Consortium

Roche's Gazyvaro and Bayer’s Adempas approved by Scottish Medicines Consortium

08-12-2014

The Scottish Medicines Consortium has decided to grant access to Gazyvaro (obinutuzumab), manufactured…

AdempasBayerCardio-vascularGazyvaroOncologyPharmaceuticalRegulationRoche

A top-20 pharma to utilize Xyntek-Antares serializing for China

A top-20 pharma to utilize Xyntek-Antares serializing for China

08-12-2014

A top 20 multi-national pharmaceutical research and manufacturer is utilizing the Xyntek-Antares solution…

ChinaPharmaceuticalProductionRegulationXyntek

Spanish government should consider linking pharmaceutical spending to GDP growth

Spanish government should consider linking pharmaceutical spending to GDP growth

08-12-2014

Pharmaceutical spending has fallen nearly 30% in Spain in last four years. According to IMS Health data,…

FinancialPharmaceuticalPoliticsPricingSpain

Latest Ph III data for UCB’s brivaracetam presented at AES

Latest Ph III data for UCB’s brivaracetam presented at AES

08-12-2014

Positive primary efficacy and safety data from the latest Phase III study evaluating Belgian drugmaker…

BRIVARACETAMNeurologicalPharmaceuticalResearchUCB

Labeling update of Lundbeck and Otsuka’s Abilify Maintena approved by FDA

08-12-2014

The US Food and Drug Administration approved the labeling update of Abilify Maintena (aripiprazole) for…

Abilify MaintenaLundbeckNeurologicalOtsuka PharmaceuticalPharmaceuticalRegulationUSA

98 to 122 of 7172 results

Back to top